The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma.
Pawinski A, Crowther D, Keizer HJ, Voûte PA, Somers R, van Glabbeke M, Lentz MA, van Oosterom AT.
Pawinski A, et al. Among authors: van glabbeke m, van oosterom at.
Eur J Cancer. 1999 Jan;35(1):163-4. doi: 10.1016/s0959-8049(98)00266-4.
Eur J Cancer. 1999.
PMID: 10211107
Clinical Trial.
No abstract available.